15804-76-9

Upstream product

• 79-24-3 Nitroethane 
• 25016-01-7 5-bromo-2-methoxybenzaldehyde 

Downstream Products

• 117379-97-2 5-methoxycarbonyl-2-methylbenzofuran 
• 219763-06-1 2-Methyl-1-benzofuran-5-carboxylic acid 
• 219764-13-3 5-carboxy-3-(2-chloro-4-phenylbenzyl)-2-methylbenzo[b]furan 
• 219763-17-4 5-carboxy-2-methyl-3-(4-phenylbenzyl)benzo[b]furan 
• 219763-07-2 3-(2,4-Dichlorobenzoyl)-5-(methoxycarbonyl)-2-methylbenzo[b]furan 
• 219764-14-4 3-(4-bromo-2-chlorobenzyl)-5-carboxy-2-methylbenzo[b]furan 
• 219763-10-7 5-carboxy-3-(2,4-dichlorobenzyl)-2-methylbenzo[b]furan 

Relevant academic research and scientific papers

Sulfonamide compounds and medicinal use thereof

A sulfonamide compound of the formula (I):R 1 --SO 2 NHCO--A--R 2 (I)wherein R 1 is alkyl, alkenyl, alkynyl and the like; A is an optionally substituted heteropolycyclic group except benzimidazolyl, indolyl, 4,7-dihydrobenzimidazolyl and 2,3-dihydrobenzoxazinyl; X is alkylene, oxa, oxa(lower)alkylene and the like; and R 2 is optionally substituted aryl, substituted biphenylyl and the like, a salt thereof and a pharmaceutical composition comprising the same. The sulfonamide compound is effective for the diseases treatable based on their blood sugar level-depressing activity, cGMP-PDE (especially PDE-V)-inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity, smooth muscle cell suppressing activity, and antiallergic activity.